Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Tallman, MS; Wang, ES; Altman, JK; Appelbaum, FR; Bhatt, VR; Bixby, D; Coutre, SE; De Lima, M; Fathi, AT; Fiorella, M; Foran, JM; Hall, AC ...
Published in: J Natl Compr Canc Netw
June 1, 2019
Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.
Duke Scholars
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
June 1, 2019
Volume
17
Issue
6
Start / End Page
721 / 749
Location
United States
Related Subject Headings
- United States
- Transplantation, Homologous
- Risk Assessment
- Remission Induction
- Oncology & Carcinogenesis
- Middle Aged
- Medical Oncology
- Leukemia, Myeloid, Acute
- Humans
- Histocompatibility Testing
Citation
APA
Chicago
ICMJE
MLA
NLM
Tallman, M. S., Wang, E. S., Altman, J. K., Appelbaum, F. R., Bhatt, V. R., Bixby, D., … Ogba, N. (2019). Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(6), 721–749. https://doi.org/10.6004/jnccn.2019.0028
Tallman, Martin S., Eunice S. Wang, Jessica K. Altman, Frederick R. Appelbaum, Vijaya Raj Bhatt, Dale Bixby, Steven E. Coutre, et al. “Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 17, no. 6 (June 1, 2019): 721–49. https://doi.org/10.6004/jnccn.2019.0028.
Tallman MS, Wang ES, Altman JK, Appelbaum FR, Bhatt VR, Bixby D, et al. Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 Jun 1;17(6):721–49.
Tallman, Martin S., et al. “Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 17, no. 6, June 2019, pp. 721–49. Pubmed, doi:10.6004/jnccn.2019.0028.
Tallman MS, Wang ES, Altman JK, Appelbaum FR, Bhatt VR, Bixby D, Coutre SE, De Lima M, Fathi AT, Fiorella M, Foran JM, Hall AC, Jacoby M, Lancet J, LeBlanc TW, Mannis G, Marcucci G, Martin MG, Mims A, O’Donnell MR, Olin R, Peker D, Perl A, Pollyea DA, Pratz K, Prebet T, Ravandi F, Shami PJ, Stone RM, Strickland SA, Wieduwilt M, Gregory KM, OCN, Hammond L, Ogba N. Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 Jun 1;17(6):721–749.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
June 1, 2019
Volume
17
Issue
6
Start / End Page
721 / 749
Location
United States
Related Subject Headings
- United States
- Transplantation, Homologous
- Risk Assessment
- Remission Induction
- Oncology & Carcinogenesis
- Middle Aged
- Medical Oncology
- Leukemia, Myeloid, Acute
- Humans
- Histocompatibility Testing